These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30955956)

  • 1. Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence?
    Brown CR; Khurshan F; Chen Z; Groeneveld PW; McCarthy F; Acker M; Rame JE; Desai N
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2315-2324.e4. PubMed ID: 30955956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device.
    Jawitz OK; Fudim M; Raman V; Blumer V; Caliskan K; DeVore AD; Mentz RJ; Milano C; Soliman O; Rogers J; Patel CB
    Ann Thorac Surg; 2020 Aug; 110(2):567-574. PubMed ID: 31904371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
    Truby LK; Farr MA; Garan AR; Givens R; Restaino SW; Latif F; Takayama H; Naka Y; Takeda K; Topkara VK
    Circulation; 2019 Aug; 140(6):459-469. PubMed ID: 31203669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplant Outcomes in Destination Therapy Left Ventricular Assist Device Patients.
    Miller RJH; Moayedi Y; Sharma A; Haddad F; Hiesinger W; Banerjee D
    ASAIO J; 2020 Apr; 66(4):394-398. PubMed ID: 31192848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End of Life with Left Ventricular Assist Device in Both Bridge to Transplant and Destination Therapy.
    Nakagawa S; Garan AR; Takayama H; Takeda K; Topkara VK; Yuzefpolskaya M; Lin SX; Colombo PC; Naka Y; Blinderman CD
    J Palliat Med; 2018 Sep; 21(9):1284-1289. PubMed ID: 29874117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.
    Truby LK; Takeda K; Topkara VK; Takayama H; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M
    J Heart Lung Transplant; 2018 Dec; 37(12):1433-1442. PubMed ID: 30206023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of donor variables on heart transplantation outcomes in mechanically bridged versus standard recipients†.
    Urban M; Booth K; Jungschleger J; Netuka I; Schueler S; MacGowan G
    Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):455-464. PubMed ID: 30169835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
    Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
    Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center.
    Park Y; Kim D; Yang JH; Cho YH; Choi JO; Jeon ES
    Korean J Intern Med; 2022 Mar; 37(2):340-349. PubMed ID: 34871480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and Functional Status After Bridge-to-Transplant with a Left Ventricular Assist Device.
    Suarez-Pierre A; Zhou X; Fraser CD; Grimm JC; Crawford TC; Lui C; Valero V; Choi CW; Higgins RS; Kilic A
    ASAIO J; 2019; 65(7):661-667. PubMed ID: 30281540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy.
    Mullan CW; Chouairi F; Sen S; Mori M; Clark KAA; Reinhardt SW; Miller PE; Fuery MA; Jacoby D; Maulion C; Anwer M; Geirsson A; Mulligan D; Formica R; Rogers JG; Desai NR; Ahmad T
    JACC Heart Fail; 2021 Jun; 9(6):420-429. PubMed ID: 33714748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal Improvement in Survival Post-Heart Transplantation in Patients With Prior Left Ventricular Assist Device: A Temporal Analysis of United Network of Organ Sharing Registry.
    Pal N; Stansfield J; Mukhopadhyay N; Nelson M
    J Cardiothorac Vasc Anesth; 2020 Feb; 34(2):392-400. PubMed ID: 31679997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of Left Ventricular Assist Device Support Does Not Impact Survival After US Heart Transplantation.
    Grimm JC; Magruder JT; Crawford TC; Fraser CD; Plum WG; Sciortino CM; Higgins RS; Whitman GJ; Shah AS
    Ann Thorac Surg; 2016 Oct; 102(4):1206-12. PubMed ID: 27319984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Moayedifar R; Zuckermann A; Aliabadi-Zuckermann A; Riebandt J; Angleitner P; Dimitrov K; Schloeglhofer T; Rajek A; Laufer G; Zimpfer D
    Eur J Cardiothorac Surg; 2018 Dec; 54(6):1116-1121. PubMed ID: 29905775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.